Navigation Links
Asoyia Announces New Mid Oleic Ultra Low Lin Soybean Oil
Date:2/12/2008

Asoyia-MO is the first and only soybean oil to provide the highest level of

stability, zero trans fats per serving, and light, clean taste.

IOWA CITY, Iowa, Feb. 12 /PRNewswire/ -- An Iowa-based soybean oil producer is introducing a new product that not only meets the increasing consumer demand for low trans fat foods, but also maintains an elevated degree of stability and neutral taste so important to food processors.

Asoyia Mid Oleic Ultra Low Lin Oil (Asoyia-MO) is made from soybeans containing high oleic content with less than 1% linolenic acid, keeping the oil fresh and shelf-stable for two to three times longer and eliminating the need for high trans fat-generating hydrogenation.

Beth Fulmer-Boyer, Asoyia vice president of sales, said food scientists will benefit from using Asoyia-MO in applications requiring longer shelf and fryer life, while providing a healthier alternative to more commonly used hydrogenated oils. As an added advantage, Asoyia-MO is made from soybean oil, often the preferred ingredient for its neutral taste.

"There is no question in my mind that whoever tries it will like it. The question for food processors is, do you need the increased stability, clean mouth feel, and low trans fats for your product, and is there a value associated with it?" Fulmer-Boyer explained.

Companies producing natural products, or shipping product overseas, should note that Asoyia-MO is produced from non-genetically modified soybeans. Regulations against the use of genetically modified ingredients in other countries require many companies to maintain separate manufacturing runs or ingredient inventories. Asoyia-MO would help alleviate those costly needs.

Asoyia-MO is the new generation of Asoyia Ultra Low Lin Oil (Asoyia-ULL), which was introduced to the market in 2004. Asoyia-ULL is made from 1% linolenic soybeans, making it the only commercially produced choice in the ultra low lin soybean oil category. Other low lin soybean oils on the market contain at least 3% linolenic acid, or three times the linolenic acid in Asoyia-ULL and Asoyia-MO.

Terri Volpe, Asoyia's technical advisor, described Asoyia-ULL as a readily available solution for tough formulations requiring a high degree of stability and zero trans fats per serving. "Asoyia-MO is the next step. It goes the extra mile for stability," she explains.

Asoyia-MO is in the early stages of production, available in small commercial quantities for processors interested in testing and evaluating it in their applications. For more information about Asoyia products and product testing, visit http://www.asoyia.com or call toll free 877-ASOYIA1.

Formed in 2004 by 25 Iowa farmers, Asoyia is now a farmer- and employee-owned company based in Iowa City, Iowa that grows and processes 1% ultra low linolenic soybeans to produce trans fat-free oils. The research, testing and expansion of Asoyia's soybean genetics dates back to the 1960s at Iowa State University, where Dr. Walt Fehr and his team developed the specialty soybean.

FOR MORE INFORMATION:

Andrea James

Office: (515)223-1383

Cell: (515) 473-2823

andrea@bigfoodideas.com


'/>"/>
SOURCE Asoyia
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... ... Today, the Centers for Medicare & Medicaid Services (CMS) announced over 359,000 ... in 2017. Clinicians who participate in APMs are paid for the quality of care ... effort to build a system that delivers better care and one in which clinicians ...
(Date:1/19/2017)... ... ... Next week after January 20th, the fear for many is that the ... needs of over 30 million. Many interviews with Dr. Carol Francis at the Los ... were suppose to prioritize. Interviews provided below. , Among those present was ...
(Date:1/19/2017)... ... January 19, 2017 , ... With the cold weather here, many people will have to clear ... when clearing large amounts of snow, but they can be dangerous when used incorrectly. That’s ... Safety Commission for the proper use of snow blowers:, , When ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... engineers, and scientists from around the world, announces the launch of its newly ... and easy portal to research breakthroughs and trending news, vital information on upcoming ...
(Date:1/19/2017)... Melville, New York (PRWEB) , ... January 19, ... ... state–of-the-art high definition dynamic telemedicine solutions, has recently unveiled impressive transportable capabilities with ... this newly designed product is an extension to RMT technology that delivers HD, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis instruments and consumables for the medical ... to discuss its financial results for the third quarter ... will be at 4:15 p.m. ET on Thursday, January ... the third quarter fiscal year 2017 after the market ...
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology: